Justinian Lane

Lunchtime Reading

First off, thank you to everyone who emailed me to let me know that is acting up.  I've engaged Typepad on the issue and hope to have the problem fixed sometime today.  Instead of visiting that site, here are a few others worth reading:

From Eric at New York Personal Injury Law Blog :

This first piece comes from Medical Economics, and was written by a Nevada physician that had been active in the tort "reform" movement there. He recounts the story of clear negligence -- admitted by the pathologist that read the slides -- and the jury verdict notwithstanding the evidence in favor of the doctor. The author and tort "reformer," medical oncologist Arnold Wax, is appalled and now understands the ramifications of what he brought to his state.

More on the Las Vegas Hepatitis story: Police Expect Lengthy Investigation Into Las Vegas Clinic

Authorities investigating the Las Vegas clinic at the center of a large hepatitis C outbreak say the investigation has been slowed by clinic workers who have refused to talk.

"I'd be very surprised if we don't go into next year," Las Vegas police Capt. Al Salinas said of the investigation of the Endoscopy center of Southern Nevada. "It's going to be a long investigation."

Bob Kraft comments on an Op-Ed regarding a Vioxx lawsuit: Personal Injury and Social Security Disability Blog: In Throwing Out Verdict, Houston Appellate Court Usurps Role Of Trial Judge And Jury

The Houston Chronicle ran an interesting commentary this weekend about the Houston Court of Civil Appeals overturning a plaintiff victory against Merck, Inc. in a Vioxx lawsuit. The gist of the article is that the appeals court has taken the place of the judge and jury. The court disregarded the decisions made by the people who were in the trial every day, and were charged with the responsibility of determining the result of the trial. The commentary implies that political donations may have had some part in the decision of the appellate judges.

Ed Silverman comments on a very disturbing trend in medical research: Fake Images Are Used To Support Research // Pharmalot

As computer programs make images easier than ever to manipulate, editors at a growing number of scientific publications are turning into image detectives, examining figures to test their authenticity. And the level of tampering they find is alarming, the paper writes. “The magnitude of the fraud is phenomenal,” Hany Farid, a computer-science professor at Dartmouth College who has been working with journal editors to help them detect image manipulation, tells the paper.

Ten to 20 of the articles accepted by The Journal of Clinical Investigation each year show some evidence of tampering, and about five to 10 of those papers warrant a thorough investigation, according to Neill. The journal publishes about 300 to 350 articles per year.

The FDA's entire yearly budget is about half of what pharmaceuticals spend to market their drugs: Pharma Marketing Blog: Professional Advertising Doing Well. DTC? Not So Much!

The recent May issue of MedAdNews lays out the facts in its 14th Annual Report on DTC: $5.37 billion was spent on DTC in 2007 vs. $5.61 in 2006 (a 4.2% decrease; see Table below).

Justinian Lane: Author Bio | Other Posts
Posted at 2:05 PM, Jun 09, 2008 in In the News
Permalink | Email to Friend